Rua Life Sciences PLC

Research Rua Life Sciences PLC (RUA) on Bullrun: market cap GBX 1.13B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerRUA
• ExchangeLSE
• CountryUnited Kingdom
• SectorHealthcare
• IndustryMedical Devices
• CurrencyGBX
• Market capGBX 1.13B
• Financial periodFY2024
• RevenueGBP 2.19M
• Revenue growth0.6%
• Net income-GBP 1.44M
• Free cash flow-GBP 1.38M
• Gross margin81.1%

Valuation Snapshot

latest market cap is GBX 1.13B.

About Rua Life Sciences PLC

RUA Life Sciences plc, together with its subsidiaries, develops medical devices in Europe, North America, the Middle East, the Asia Pacific, and Africa. It operates through four segments: Biomaterials, Contract Manufacture, Vascular, and Structural Heart. The company acts as the depository of intellectual property and licensing rights to various biostable and implantable polymers, including Elast-Eon and ECSil;

Frequently asked questions

What is Rua Life Sciences PLC's market cap?

Rua Life Sciences PLC's market capitalization is GBX 1.13B.

What does Rua Life Sciences PLC do?

RUA Life Sciences plc, together with its subsidiaries, develops medical devices in Europe, North America, the Middle East, the Asia Pacific, and Africa. It operates through four segments: Biomaterials, Contract Manufacture, Vascular, and Structural Heart.